The renin‐angiotensin‐aldosterone system and its suppression

MK Ames, CE Atkins, B Pitt - Journal of veterinary internal …, 2019 - Wiley Online Library
Chronic activation of the renin‐angiotensin‐aldosterone system (RAAS) promotes and
perpetuates the syndromes of congestive heart failure, systemic hypertension, and chronic …

Improving the residual risk of renal and cardiovascular outcomes in diabetic kidney disease: a review of pathophysiology, mechanisms, and evidence from recent trials

A Chaudhuri, H Ghanim, P Arora - Diabetes, Obesity and …, 2022 - Wiley Online Library
Based on global estimates, almost 10% of adults have diabetes, of whom 40% are estimated
to also have chronic kidney disease (CKD). Almost 2 decades ago, treatments targeting the …

[HTML][HTML] Role of the renin-angiotensin-aldosterone system beyond blood pressure regulation: molecular and cellular mechanisms involved in end-organ damage …

N Muñoz-Durango, CA Fuentes, AE Castillo… - International journal of …, 2016 - mdpi.com
Arterial hypertension is a common condition worldwide and an important predictor of several
complicated diseases. Arterial hypertension can be triggered by many factors, including …

Hypertension in obesity and the impact of weight loss

JB Cohen - Current cardiology reports, 2017 - Springer
Abstract Purpose of Review Several interrelated mechanisms promote the development of
hypertension in obesity, often contributing to end organ damage including cardiovascular …

Atrial fibrillation and hypertension

MS Dzeshka, A Shantsila, E Shantsila, GYH Lip - Hypertension, 2017 - Am Heart Assoc
Pathophysiologically lower BPs results in less strain on the LV, and, thus, more aggressive
BP control may have benefits in terms of LV hypertrophy, myocardial fibrosis, diastolic …

[PDF][PDF] Cardiovascular disease after liver transplantation: when, what, and who is at risk

LA Fussner, JK Heimbach, C Fan… - Liver …, 2015 - Wiley Online Library
The evolution of metabolic and cardiovascular disease (CVD) complications after liver
transplantation (LT) is poorly characterized. We aim to illustrate the prevalence of obesity …

Steroidal and novel non-steroidal mineralocorticoid receptor antagonists in heart failure and cardiorenal diseases: comparison at bench and bedside

P Kolkhof, F Jaisser, SY Kim, G Filippatos, C Nowack… - Heart failure, 2017 - Springer
Abstract Characterization of mice with cell-specific deletion or overexpression of the
mineralocorticoid receptor (MR) shed a new light on its role in health and disease …

The metabolic syndrome and chronic kidney disease

X Zhang, LO Lerman - Translational Research, 2017 - Elsevier
The metabolic syndrome (MetS) is a cluster of cardiovascular risk factors including insulin
resistance (IR), dyslipidemia, and hypertension, which may also foster development of …

The role of aldosterone in obesity-related hypertension

W Kawarazaki, T Fujita - American journal of hypertension, 2016 - academic.oup.com
Obese subjects often have hypertension and related cardiovascular and renal diseases, and
this has become a serious worldwide health problem. In obese subjects, impaired renal …

[HTML][HTML] Atrial natriuretic peptide: a molecular target of novel therapeutic approaches to cardio-metabolic disease

V Cannone, A Cabassi, R Volpi… - International journal of …, 2019 - mdpi.com
Atrial natriuretic peptide (ANP) is a cardiac hormone with pleiotropic cardiovascular and
metabolic properties including vasodilation, natriuresis and suppression of the renin …